findmyKOL
Clinical trialNCT07083154RecruitingPhase 3Interventional

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolEnrollment420Dementia, MildMild Cognitive ImpairmentType 2 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Yan Bi, MD, PhD

    Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Department of Endocrinology, Xiangya Hospital of Central South University

    Changsha, Hunan, China

    Jing Wu, MD, PhD
    Not, yet, recruiting
  • Department of Endocrinology, Changzhou No.2 People'S Hospital

    Changzhou, Jiangsu, China

    Huijie Yang, MDXinhua Ye, MD, PhD
    Recruiting
  • Department of Endocrinology, Endocrine and Metabolic Disease Medical Center,nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

    Nanjing, Jiangsu, China

    Yan Bi, MD, PhDZhou Zhang, MD, PhD
    Recruiting
  • Department of Endocrinology, Jiangsu Province Hospital of Traditional Chinese Medicine

    Nanjing, Jiangsu, China

    Yueting Zhao, MD
    Recruiting
  • Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University

    Nanjing, Jiangsu, China

    Jindan Wu, MD, PhDPeng Zhang, MD
    Recruiting
  • the Second Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China

    Haixia Liu, MD, PhD
    Not, yet, recruiting
  • Department of Endocrinology, Shanghai General Hospital

    Shanghai, Shanghai Municipality, China

    Fang Fang, MD,PhD
    Recruiting
  • Department of Endocrinology, Huadong Hospital Affiliated To Fudan University

    Shanghai, China

    Bin Lu, MD, PhDCuiping Jiang, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Sept 2025
Primary completion
1 Aug 2029
Completion
1 Aug 2029
Last update posted
5 Mar 2026
Registered enrollment
420
Registry id
NCT07083154

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.